Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Name: Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
Published: 2025
License: Public Domain

Vall d'Hebron Institute of Oncology · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

cervical-cancer melanoma non-small-cell-lung-cancer

melanoma, non small cell lung cancer, cervical cancer, immune checkpoint blockade (icb) resistant tumors, tumor-infiltrating lymphocyte, adoptive cell therapy, interleukin-2 (il-2), interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Related documents